Sepsis pathophysiology: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
m (Bot: Removing from Primary care)
 
(17 intermediate revisions by 5 users not shown)
Line 5: Line 5:
|}
|}
{{Sepsis}}
{{Sepsis}}
{{CMG}};  '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org]
{{CMG}};  '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org] ; {{ADG}}


{{SK}} sepsis syndrome; septic shock; septicemia
{{SK}} sepsis syndrome; septic shock; septicemia


==Overview==
==Overview==
The immunological response that causes sepsis is a systemic inflammatory response causing widespread activation of [[inflammation]] and [[coagulation]] pathways. This may progress to dysfunction of the [[septic shock|circulatory system]] and, even under optimal treatment, may result in the [[multiple organ dysfunction syndrome]] and eventually [[death]]. A subclass of [[distributive shock]], with shock referring specifically to decreased tissue [[perfusion]] resulting in end-organ dysfunction. [[Cytokines]] [[TNFα]], [[interleukin|IL]]-1β, [[interferon]] γ, [[interleukin|IL]]-6 released in a large scale inflammatory response results in massive [[vasodilation]], increased [[capillary]] permeability, decreased systemic vascular resistance, and [[hypotension]].  Hypotension reduces tissue perfusion pressure and thus tissue [[Hypoxia (medical)|hypoxia]] ensues.  Finally, in an attempt to offset decreased [[blood pressure]], [[ventricular]] dilatation and [[myocardium|myocardial]] dysfunction will occur.
The immunological response that causes sepsis is a systemic inflammatory response causing widespread activation of [[inflammation]] and [[coagulation]] pathways. This may progress to dysfunction of the [[septic shock|circulatory system]] and, even under optimal treatment, may result in the [[multiple organ dysfunction syndrome]] and eventually [[death]]. A subclass of [[distributive shock]], with shock referring specifically to decreased tissue [[perfusion]] resulting in end-organ dysfunction. [[Cytokines]] [[TNFα]], [[interleukin|IL]]-1β, [[interferon]] γ, [[interleukin|IL]]-6 released in a large scale inflammatory response results in massive [[vasodilation]], increased [[capillary]] permeability, decreased systemic vascular resistance, and [[hypotension]].  Hypotension reduces tissue perfusion pressure and thus tissue [[Hypoxia (medical)|hypoxia]] ensues.  Finally, in an attempt to offset decreased [[blood pressure]], [[ventricular]] dilatation and [[myocardium|myocardial]] dysfunction will occur. <ref name="pmid28448952">{{cite journal |vauthors=Minasyan H |title=Sepsis and septic shock: Pathogenesis and treatment perspectives |journal=J Crit Care |volume=40 |issue= |pages=229–242 |year=2017 |pmid=28448952 |doi=10.1016/j.jcrc.2017.04.015 |url=}}</ref><ref name="pmid25870671">{{cite journal |vauthors=Pop-Began V, Păunescu V, Grigorean V, Pop-Began D, Popescu C |title=Molecular mechanisms in the pathogenesis of sepsis |journal=J Med Life |volume=7 Spec No. 2 |issue= |pages=38–41 |year=2014 |pmid=25870671 |pmc=4391358 |doi= |url=}}</ref><ref name="pmid20887193">{{cite journal |vauthors=Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG |title=The pathogenesis of sepsis |journal=Annu Rev Pathol |volume=6 |issue= |pages=19–48 |year=2011 |pmid=20887193 |pmc=3684427 |doi=10.1146/annurev-pathol-011110-130327 |url=}}</ref><ref name="pmid14767363">{{cite journal |vauthors=Cunneen J, Cartwright M |title=The puzzle of sepsis: fitting the pieces of the inflammatory response with treatment |journal=AACN Clin Issues |volume=15 |issue=1 |pages=18–44 |year=2004 |pmid=14767363 |doi= |url=}}</ref><ref name="pmid24292568">{{cite journal |vauthors=Chaudhry H, Zhou J, Zhong Y, Ali MM, McGuire F, Nagarkatti PS, Nagarkatti M |title=Role of cytokines as a double-edged sword in sepsis |journal=In Vivo |volume=27 |issue=6 |pages=669–84 |year=2013 |pmid=24292568 |pmc=4378830 |doi= |url=}}</ref>
 
==Pathophysiology==
*[[Sepsis]] is defined as a collection of physiologic responses by the [[immune system]] in response to an [[infectious agent]].
*[[Sepsis]] results when an infectious insult triggers a [[Immune response|localized inflammatory reaction]] that resulting in systemic symptoms of [[fever]] or [[hypothermia]], [[tachycardia]], [[tachypnea]], and either [[leukocytosis]] or [[leukopenia]].
*The clinical course of sepsis depends on the type and [[resistance]] of the infectious organism, the site and size of the infecting insult, and the genetically determined or acquired properties of the host's [[Immune system|immune system.]]
*The pathogenesis of sepsis can be discussed as follows <ref name="pmid25870671">{{cite journal |vauthors=Pop-Began V, Păunescu V, Grigorean V, Pop-Began D, Popescu C |title=Molecular mechanisms in the pathogenesis of sepsis |journal=J Med Life |volume=7 Spec No. 2 |issue= |pages=38–41 |year=2014 |pmid=25870671 |pmc=4391358 |doi= |url=}}</ref><ref name="pmid20887193">{{cite journal |vauthors=Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG |title=The pathogenesis of sepsis |journal=Annu Rev Pathol |volume=6 |issue= |pages=19–48 |year=2011 |pmid=20887193 |pmc=3684427 |doi=10.1146/annurev-pathol-011110-130327 |url=}}</ref><ref name="pmid14767363">{{cite journal |vauthors=Cunneen J, Cartwright M |title=The puzzle of sepsis: fitting the pieces of the inflammatory response with treatment |journal=AACN Clin Issues |volume=15 |issue=1 |pages=18–44 |year=2004 |pmid=14767363 |doi= |url=}}</ref><ref name="pmid24292568">{{cite journal |vauthors=Chaudhry H, Zhou J, Zhong Y, Ali MM, McGuire F, Nagarkatti PS, Nagarkatti M |title=Role of cytokines as a double-edged sword in sepsis |journal=In Vivo |volume=27 |issue=6 |pages=669–84 |year=2013 |pmid=24292568 |pmc=4378830 |doi= |url=}}</ref>
 
===Immune system activation===
*The [[immune system]] is activated by [[pathogen]] entry which is facilitated by [[contamination]] of tissue either by surgery or [[infection]], [[foreign body]] insertion (catheters) and in an [[Immunocompromised|immunocompromised state]].
*Products of activation include
**Bacterial cell wall products such as [[lipopolysaccharide]]
**Binding to host receptors, including [[Toll-like receptors]] ([[Toll-like receptors|TLR]]<nowiki/>s).
*Toll-like receptors are found in [[leukocytes]] and [[macrophages]], and [[endothelial cells]].
*These have specificity for different [[Bacteria|bacterial]], [[Fungus|fungal]], or viral products.
*[[Toll-like receptors|TLR]]<nowiki/>s are associated with a predisposition to shock with [[gram-negative]] organisms.
*Activation of the [[innate immune system]] results in a complex series of [[Immune response|cellular and humoral responses]].
 
===Immune response===
*[[Immune response]] includes the release of pro-inflammatory [[cytokines]], such as [[Tumour necrosis factor|tumor necrosis factor]] (TNF)-alpha and [[Interleukins|interleukins 1]] and 6 along with [[reactive oxygen species]], [[nitric oxide]] (NO), [[proteases]], and pore-forming molecules, which bring about activation of immune cells and bacterial killing.
*[[Nitrous oxide]] is responsible for [[vasodilatation]] and [[increased capillary permeability]] and has been implicated in sepsis-induced mitochondrial dysfunction.
*The [[complement system]]  gets activated which mediates activation of [[leukocytes]], attracting them to the site of infection ([[phagocytes]], cytotoxic [[T lymphocytes]]),
*Complement system also helps as a mediator for [[antigen-presenting cells]] and [[B lymphocytes]]
*This response by complement system helps the [[B lymphocyte]] to produce [[Memory B cell|memory cells]] in case of future infection and is responsible for the increased production and chemotaxis of more [[T helper cells|T helper cells.]]
 
===The endothelium and coagulation system===
*The vascular [[endothelium]] plays a major role in the host's defense to an invading organism, but also in the development of sepsis.
*Activated [[endothelium]] not only allows the adhesion and migration of stimulated immune cells but becomes porous to large molecules such as proteins, resulting in the tissue edema.
*Alterations in the [[Coagulation system|coagulation systems]] include an increase in procoagulant factors, such as [[plasminogen activator]] inhibitor type I and tissue factor, and reduced circulating levels of natural [[anticoagulants]], including [[antithrombin III]] and [[activated protein C]] (APC), which also carry anti-inflammatory and modulatory roles.
===Inflammation and organ dysfunction===
*Through vasodilatation (causing reduced systemic vascular resistance) and increased capillary permeability (causing extravasation of [[plasma]]), sepsis results in relative and absolute reductions in circulating volume.
*A number of factors combine to produce [[Multiple organ dysfunction syndrome|multiple organ dysfunctions]].
*Relative and absolute [[hypovolemia]] are compounded by reduced left ventricular contractility to produce [[hypotension]].
*Initially, through an increased heart rate, cardiac output increases to compensate and maintain perfusion pressures, but as this compensatory mechanism becomes exhausted, [[hypoperfusion]] and [[shock]] may result.
*Impaired tissue oxygen delivery is exacerbated by pericapillary edema.
*It makes oxygen to diffuse a greater distance to reach target cells.
*There is a reduction of capillary diameter due to mural [[edema]] and the procoagulant state results in capillary microthrombus formation.
===Additional contributing factors===
*Decreased blood flow through capillary beds, resulting from a combination of shunting of blood through collateral channels and an increase in blood viscosity secondary to loss of red cell flexibility.
*As a result, organs become [[hypoxic]], even with increased blood flow.
*These abnormalities result in [[lactic acidosis]], cellular dysfunction, and [[multiorgan failure]].
*Cellular energy levels fall as metabolic activity begins to exceed production.
*However, [[cell death]] appears to be uncommon in [[sepsis]], implying that cells shut down as part of the systemic response.
*This could explain why relatively few histologic changes are found at autopsy, and the eventual rapid resolution of severe symptoms, such as complete anuria and hypotension, once the systemic inflammation resolves.
 
===Genetics===
There are no genetic conditions associated with sepsis.


==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WS}}
[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Causes of death]]
[[Category:Causes of death]]
[[Category:Intensive care medicine]]
[[Category:Intensive care medicine]]
[[Category:Infectious disease]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Disease]]
{{WH}}
[[Category:Emergency mdicine]]
{{WS}}
[[Category:Up-To-Date]]
[[Category:Infectious disease]]

Latest revision as of 00:08, 30 July 2020

Resident
Survival
Guide

Sepsis Microchapters

Home

Patient Information (Adult)

Patient Information (Neonatal)

Overview

Pathophysiology

Causes

Differentiating Sepsis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sepsis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sepsis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sepsis pathophysiology

CDC on Sepsis pathophysiology

Sepsis pathophysiology in the news

Blogs on Sepsis pathophysiology

Directions to Hospitals Treating Sepsis

Risk calculators and risk factors for Sepsis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2] ; Aditya Ganti M.B.B.S. [3]

Synonyms and keywords: sepsis syndrome; septic shock; septicemia

Overview

The immunological response that causes sepsis is a systemic inflammatory response causing widespread activation of inflammation and coagulation pathways. This may progress to dysfunction of the circulatory system and, even under optimal treatment, may result in the multiple organ dysfunction syndrome and eventually death. A subclass of distributive shock, with shock referring specifically to decreased tissue perfusion resulting in end-organ dysfunction. Cytokines TNFα, IL-1β, interferon γ, IL-6 released in a large scale inflammatory response results in massive vasodilation, increased capillary permeability, decreased systemic vascular resistance, and hypotension. Hypotension reduces tissue perfusion pressure and thus tissue hypoxia ensues. Finally, in an attempt to offset decreased blood pressure, ventricular dilatation and myocardial dysfunction will occur. [1][2][3][4][5]

Pathophysiology

Immune system activation

Immune response

The endothelium and coagulation system

  • The vascular endothelium plays a major role in the host's defense to an invading organism, but also in the development of sepsis.
  • Activated endothelium not only allows the adhesion and migration of stimulated immune cells but becomes porous to large molecules such as proteins, resulting in the tissue edema.
  • Alterations in the coagulation systems include an increase in procoagulant factors, such as plasminogen activator inhibitor type I and tissue factor, and reduced circulating levels of natural anticoagulants, including antithrombin III and activated protein C (APC), which also carry anti-inflammatory and modulatory roles.

Inflammation and organ dysfunction

  • Through vasodilatation (causing reduced systemic vascular resistance) and increased capillary permeability (causing extravasation of plasma), sepsis results in relative and absolute reductions in circulating volume.
  • A number of factors combine to produce multiple organ dysfunctions.
  • Relative and absolute hypovolemia are compounded by reduced left ventricular contractility to produce hypotension.
  • Initially, through an increased heart rate, cardiac output increases to compensate and maintain perfusion pressures, but as this compensatory mechanism becomes exhausted, hypoperfusion and shock may result.
  • Impaired tissue oxygen delivery is exacerbated by pericapillary edema.
  • It makes oxygen to diffuse a greater distance to reach target cells.
  • There is a reduction of capillary diameter due to mural edema and the procoagulant state results in capillary microthrombus formation.

Additional contributing factors

  • Decreased blood flow through capillary beds, resulting from a combination of shunting of blood through collateral channels and an increase in blood viscosity secondary to loss of red cell flexibility.
  • As a result, organs become hypoxic, even with increased blood flow.
  • These abnormalities result in lactic acidosis, cellular dysfunction, and multiorgan failure.
  • Cellular energy levels fall as metabolic activity begins to exceed production.
  • However, cell death appears to be uncommon in sepsis, implying that cells shut down as part of the systemic response.
  • This could explain why relatively few histologic changes are found at autopsy, and the eventual rapid resolution of severe symptoms, such as complete anuria and hypotension, once the systemic inflammation resolves.

Genetics

There are no genetic conditions associated with sepsis.

References

  1. Minasyan H (2017). "Sepsis and septic shock: Pathogenesis and treatment perspectives". J Crit Care. 40: 229–242. doi:10.1016/j.jcrc.2017.04.015. PMID 28448952.
  2. 2.0 2.1 Pop-Began V, Păunescu V, Grigorean V, Pop-Began D, Popescu C (2014). "Molecular mechanisms in the pathogenesis of sepsis". J Med Life. 7 Spec No. 2: 38–41. PMC 4391358. PMID 25870671.
  3. 3.0 3.1 Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG (2011). "The pathogenesis of sepsis". Annu Rev Pathol. 6: 19–48. doi:10.1146/annurev-pathol-011110-130327. PMC 3684427. PMID 20887193.
  4. 4.0 4.1 Cunneen J, Cartwright M (2004). "The puzzle of sepsis: fitting the pieces of the inflammatory response with treatment". AACN Clin Issues. 15 (1): 18–44. PMID 14767363.
  5. 5.0 5.1 Chaudhry H, Zhou J, Zhong Y, Ali MM, McGuire F, Nagarkatti PS, Nagarkatti M (2013). "Role of cytokines as a double-edged sword in sepsis". In Vivo. 27 (6): 669–84. PMC 4378830. PMID 24292568.

Template:WH Template:WS